[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Drugs for Osteoarthritis Pain Industry Research Report 2024

February 2024 | 101 pages | ID: DA1DC9B75973EN
APO Research

US$ 2,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report aims to provide a comprehensive presentation of the global market for Drugs for Osteoarthritis Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Osteoarthritis Pain.

The Drugs for Osteoarthritis Pain market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs for Osteoarthritis Pain market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drugs for Osteoarthritis Pain companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • Pfizer
  • Johnson & Johnson
  • GlaxoSmithKline
  • Bayer
  • Eli Lilly
  • Novartis
  • Sanofi
  • Horizon Pharma
  • Abbott
  • Mylan
  • Daiichi Sankyo
  • TEVA
  • Almatica Pharma
  • Astellas Pharma
  • Tide Pharmaceutical
  • Iroko Pharmaceuticals
  • Hengrui Pharmaceutical
  • Abiogen Pharma
Product Type Insights

Global markets are presented by Drugs for Osteoarthritis Pain type, along with growth forecasts through 2030. Estimates on revenue are based on the price in the supply chain at which the Drugs for Osteoarthritis Pain are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).

Drugs for Osteoarthritis Pain segment by Type
  • Oral
  • Injection
  • External
Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).

This report also outlines the market trends of each segment and consumer behaviors impacting the Drugs for Osteoarthritis Pain market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Drugs for Osteoarthritis Pain market.

Drugs for Osteoarthritis Pain Segment by Application
  • Medical Care
  • Personal Care
Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2019-2030.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Drugs for Osteoarthritis Pain market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Osteoarthritis Pain market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Drugs for Osteoarthritis Pain and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Drugs for Osteoarthritis Pain industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Osteoarthritis Pain.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Drugs for Osteoarthritis Pain companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.
1 PREFACE

1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
  1.5.1 Secondary Sources
  1.5.2 Primary Sources

2 MARKET OVERVIEW

2.1 Product Definition
2.2 Drugs for Osteoarthritis Pain by Type
  2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
  1.2.2 Oral
  1.2.3 Injection
  1.2.4 External
2.3 Drugs for Osteoarthritis Pain by Application
  2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
  2.3.2 Medical Care
  2.3.3 Personal Care
2.4 Assumptions and Limitations

3 DRUGS FOR OSTEOARTHRITIS PAIN BREAKDOWN DATA BY TYPE

3.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Type (2019-2024)
3.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2025-2030)

4 DRUGS FOR OSTEOARTHRITIS PAIN BREAKDOWN DATA BY APPLICATION

4.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Application (2019-2024)
4.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2019-2024)

5 GLOBAL GROWTH TRENDS

5.1 Global Drugs for Osteoarthritis Pain Market Perspective (2019-2030)
5.2 Global Drugs for Osteoarthritis Pain Growth Trends by Region
  5.2.1 Global Drugs for Osteoarthritis Pain Market Size by Region: 2019 VS 2023 VS 2030
  5.2.2 Drugs for Osteoarthritis Pain Historic Market Size by Region (2019-2024)
  5.2.3 Drugs for Osteoarthritis Pain Forecasted Market Size by Region (2025-2030)
5.3 Drugs for Osteoarthritis Pain Market Dynamics
  5.3.1 Drugs for Osteoarthritis Pain Industry Trends
  5.3.2 Drugs for Osteoarthritis Pain Market Drivers
  5.3.3 Drugs for Osteoarthritis Pain Market Challenges
  5.3.4 Drugs for Osteoarthritis Pain Market Restraints

6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS

6.1 Global Top Drugs for Osteoarthritis Pain Players by Revenue
  6.1.1 Global Top Drugs for Osteoarthritis Pain Players by Revenue (2019-2024)
  6.1.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Players (2019-2024)
6.2 Global Drugs for Osteoarthritis Pain Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Drugs for Osteoarthritis Pain Head office and Area Served
6.4 Global Drugs for Osteoarthritis Pain Players, Product Type & Application
6.5 Global Drugs for Osteoarthritis Pain Players, Date of Enter into This Industry
6.6 Global Drugs for Osteoarthritis Pain Market CR5 and HHI
6.7 Global Players Mergers & Acquisition

7 NORTH AMERICA

7.1 North America Drugs for Osteoarthritis Pain Market Size (2019-2030)
7.2 North America Drugs for Osteoarthritis Pain Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Drugs for Osteoarthritis Pain Market Size by Country (2019-2024)
7.4 North America Drugs for Osteoarthritis Pain Market Size by Country (2025-2030)
7.5 United States
7.6 Canada

8 EUROPE

8.1 Europe Drugs for Osteoarthritis Pain Market Size (2019-2030)
8.2 Europe Drugs for Osteoarthritis Pain Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Drugs for Osteoarthritis Pain Market Size by Country (2019-2024)
8.4 Europe Drugs for Osteoarthritis Pain Market Size by Country (2025-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries

9 ASIA-PACIFIC

9.1 Asia-Pacific Drugs for Osteoarthritis Pain Market Size (2019-2030)
9.2 Asia-Pacific Drugs for Osteoarthritis Pain Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Country (2019-2024)
9.4 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Country (2025-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia

10 LATIN AMERICA

10.1 Latin America Drugs for Osteoarthritis Pain Market Size (2019-2030)
10.2 Latin America Drugs for Osteoarthritis Pain Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Drugs for Osteoarthritis Pain Market Size by Country (2019-2024)
10.4 Latin America Drugs for Osteoarthritis Pain Market Size by Country (2025-2030)
9.4 Mexico
9.5 Brazil

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Drugs for Osteoarthritis Pain Market Size (2019-2030)
11.2 Middle East & Africa Drugs for Osteoarthritis Pain Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2019-2024)
11.4 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2025-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE

12 PLAYERS PROFILED

11.1 Pfizer
  11.1.1 Pfizer Company Detail
  11.1.2 Pfizer Business Overview
  11.1.3 Pfizer Drugs for Osteoarthritis Pain Introduction
  11.1.4 Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
  11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
  11.2.1 Johnson & Johnson Company Detail
  11.2.2 Johnson & Johnson Business Overview
  11.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Introduction
  11.2.4 Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
  11.2.5 Johnson & Johnson Recent Development
11.3 GlaxoSmithKline
  11.3.1 GlaxoSmithKline Company Detail
  11.3.2 GlaxoSmithKline Business Overview
  11.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Introduction
  11.3.4 GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
  11.3.5 GlaxoSmithKline Recent Development
11.4 Bayer
  11.4.1 Bayer Company Detail
  11.4.2 Bayer Business Overview
  11.4.3 Bayer Drugs for Osteoarthritis Pain Introduction
  11.4.4 Bayer Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
  11.4.5 Bayer Recent Development
11.5 Eli Lilly
  11.5.1 Eli Lilly Company Detail
  11.5.2 Eli Lilly Business Overview
  11.5.3 Eli Lilly Drugs for Osteoarthritis Pain Introduction
  11.5.4 Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
  11.5.5 Eli Lilly Recent Development
11.6 Novartis
  11.6.1 Novartis Company Detail
  11.6.2 Novartis Business Overview
  11.6.3 Novartis Drugs for Osteoarthritis Pain Introduction
  11.6.4 Novartis Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
  11.6.5 Novartis Recent Development
11.7 Sanofi
  11.7.1 Sanofi Company Detail
  11.7.2 Sanofi Business Overview
  11.7.3 Sanofi Drugs for Osteoarthritis Pain Introduction
  11.7.4 Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
  11.7.5 Sanofi Recent Development
11.8 Horizon Pharma
  11.8.1 Horizon Pharma Company Detail
  11.8.2 Horizon Pharma Business Overview
  11.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Introduction
  11.8.4 Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
  11.8.5 Horizon Pharma Recent Development
11.9 Abbott
  11.9.1 Abbott Company Detail
  11.9.2 Abbott Business Overview
  11.9.3 Abbott Drugs for Osteoarthritis Pain Introduction
  11.9.4 Abbott Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
  11.9.5 Abbott Recent Development
11.10 Mylan
  11.10.1 Mylan Company Detail
  11.10.2 Mylan Business Overview
  11.10.3 Mylan Drugs for Osteoarthritis Pain Introduction
  11.10.4 Mylan Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
  11.10.5 Mylan Recent Development
11.11 Daiichi Sankyo
  11.11.1 Daiichi Sankyo Company Detail
  11.11.2 Daiichi Sankyo Business Overview
  11.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Introduction
  11.11.4 Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
  11.11.5 Daiichi Sankyo Recent Development
11.12 TEVA
  11.12.1 TEVA Company Detail
  11.12.2 TEVA Business Overview
  11.12.3 TEVA Drugs for Osteoarthritis Pain Introduction
  11.12.4 TEVA Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
  11.12.5 TEVA Recent Development
11.13 Almatica Pharma
  11.13.1 Almatica Pharma Company Detail
  11.13.2 Almatica Pharma Business Overview
  11.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Introduction
  11.13.4 Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
  11.13.5 Almatica Pharma Recent Development
11.14 Astellas Pharma
  11.14.1 Astellas Pharma Company Detail
  11.14.2 Astellas Pharma Business Overview
  11.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Introduction
  11.14.4 Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
  11.14.5 Astellas Pharma Recent Development
11.15 Tide Pharmaceutical
  11.15.1 Tide Pharmaceutical Company Detail
  11.15.2 Tide Pharmaceutical Business Overview
  11.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Introduction
  11.15.4 Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
  11.15.5 Tide Pharmaceutical Recent Development
11.16 Iroko Pharmaceuticals
  11.16.1 Iroko Pharmaceuticals Company Detail
  11.16.2 Iroko Pharmaceuticals Business Overview
  11.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Introduction
  11.16.4 Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
  11.16.5 Iroko Pharmaceuticals Recent Development
11.17 Hengrui Pharmaceutical
  11.17.1 Hengrui Pharmaceutical Company Detail
  11.17.2 Hengrui Pharmaceutical Business Overview
  11.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Introduction
  11.17.4 Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
  11.17.5 Hengrui Pharmaceutical Recent Development
11.18 Abiogen Pharma
  11.18.1 Abiogen Pharma Company Detail
  11.18.2 Abiogen Pharma Business Overview
  11.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Introduction
  11.18.4 Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
  11.18.5 Abiogen Pharma Recent Development

13 REPORT CONCLUSION

14 DISCLAIMER



More Publications